Abstract
Gonadotrophic axis dysfunction is commonly observed in HIV-infected patients. The pathogenesis is multifactorial and related to duration of HIV infection, direct cytopathic effects of viruses, use of drugs, opportunistic infections, malignancies, and malnutrition, among other factors. In men, reduced levels of testosterone is associated with loss of muscle mass and strength, decreased bone mineral density, lipodystrophy, depression, asthenia, fatigue and sexual dysfunction. In HIV-infected patients with hypogonadism, numerous studies have shown the beneficial effects of testosterone replacement on the metabolic profile and distribution of body fat, with increased body mass weight, and promote better quality of life, reduce the bone mass loss and the rates of depression. Thus, this review aimed to present a brief update of epidemiologic data, pathophysiology aspects and treatment strategies for the major abnormalities of male gonadotrophic axis associated with HIV infection and its treatment.
References
Nov 1, 1992·Endocrinology·D B Hales
Jan 1, 1991·Endocrinology·X F XuP Björntorp
Mar 1, 1990·The Journal of Clinical Endocrinology and Metabolism·J A MerenichG S Kidd
Sep 1, 1990·Metabolism: Clinical and Experimental·J C SeidellR Sannerstedt
Mar 1, 1989·Human Pathology·M E De Paepe, M Waxman
Mar 1, 1988·The American Journal of Medicine·A S DobsB F Polk
Jun 1, 1987·Urology·A B ChabonH Grabstald
Oct 1, 1995·European Journal of Endocrinology·A LaudatJ Giboudeau
Jun 1, 1993·Endocrinology·Y Xiong, D B Hales
Dec 1, 1996·AIDS·J R BergerR Dudley
Mar 5, 1998·Toxicology Letters·T InabaT Hidaka
Jul 4, 1998·Lancet·A CarrD A Cooper
Jul 4, 1998·Annals of Internal Medicine·S GrinspoonA Klibanski
Oct 30, 1998·The Annals of Pharmacotherapy·K M MelbourneF J Silverblatt
Jan 14, 1999·Urology·M M ShevchukJ A Fracchia
Apr 23, 1999·Journal of Reproductive Immunology·M M ShevchukG Khalife
Apr 24, 1999·International Journal of STD & AIDS·B DonovanD Allen
Aug 25, 1999·The American Journal of Medicine·A S DobsF Rhame
Nov 5, 1999·AIDS·H PeyriereP Balmes
Feb 22, 2000·JAMA : the Journal of the American Medical Association·S BhasinG Beall
Oct 21, 2000·Lancet·J HutchinsonC J Skinner
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P RietschelS Grinspoon
Jun 26, 2001·Clinical Endocrinology·A ParraA Ruiz-Argüelles
Apr 27, 2002·HIV Clinical Trials·Julio CollazosJosé Mayo
Oct 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Devon L EvansDavid M Aboulafia
Mar 28, 2003·The Annals of Pharmacotherapy·Patrick G Clay, Amy I Lam
Aug 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Odelia B CooperAdrian S Dobs
Jun 29, 2005·Diabetes Care·Nelly PitteloudFrances J Hayes
Jul 2, 2005·Annals of Clinical Biochemistry·Sashi AcharyaRousseau Gama
Oct 20, 2005·AIDS Patient Care and STDs·Nancy F CrumMark R Wallace
Nov 17, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert S KleinAdrian S Dobs
May 27, 2006·European Journal of Endocrinology·D KapoorT H Jones
Dec 14, 2006·The Journal of Clinical Endocrinology and Metabolism·Shalender BhasinUNKNOWN AIDS Clinical Trials Group Protocol A5079 Study Team
Feb 1, 2007·AIDS Patient Care and STDs·Nancy F Crum-CianfloneMark R Wallace
Jun 5, 2007·Endocrinology and Metabolism Clinics of North America·Rita R KalyaniAdrian S Dobs
Jul 31, 2008·The Journal of Clinical Endocrinology and Metabolism·Susan A HallJohn B McKinlay
Jan 28, 2009·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Julio Collazos, Margarita Esteban
Mar 5, 2009·European Journal of Medical Research·J TeichmannR G Bretzel